India And U.S. Pharma Companies Meet To Discuss Evolving Partnership Models
This article was originally published in PharmAsia News
Executive Summary
CAMBRIDGE, Mass. - The ever-growing engagement of the Indian pharmaceutical industry with its global counterparts - in the areas of R&D partnerships, manufacturing alliances to M&As - could be gauged from the coming together of senior level industry executives from both sides at the annual biopharma and healthcare summit sponsored by the USA-India Chamber of Commerce (USAIC) in Cambridge, Massachusetts June 23
You may also be interested in...
Ahead Of UN Meeting, Stakeholders Urged To Embrace Fight Against NCDs - IFPMA Report
HONG KONG - Large discrepancies in wealth, weak access to healthcare and poor distribution networks are among the key challenges developing nations face in tackling the growing threat of non-communicable diseases
Ahead Of UN Meeting, Stakeholders Urged To Embrace Fight Against NCDs - IFPMA Report
HONG KONG - Large discrepancies in wealth, weak access to healthcare and poor distribution networks are among the key challenges developing nations face in tackling the growing threat of non-communicable diseases
Pharma Companies Urge Reduced Barriers To Access Ahead Of UN Meeting On Non-communicable Disease In Developing Countries
HONG KONG - The growing incidence of non-communicable diseases is driving health authorities, non-governmental organizations and pharmaceutical companies to shift priorities. In September, the United Nations plans to hold a high level meeting on NCDs to address "prevention and control," particularly in developing countries